243 related articles for article (PubMed ID: 29986997)
1. Therapeutic Targeting of the Premetastatic Stage in Human Lung-to-Brain Metastasis.
Singh M; Venugopal C; Tokar T; McFarlane N; Subapanditha MK; Qazi M; Bakhshinyan D; Vora P; Murty NK; Jurisica I; Singh SK
Cancer Res; 2018 Sep; 78(17):5124-5134. PubMed ID: 29986997
[TBL] [Abstract][Full Text] [Related]
2. RNAi screen identifies essential regulators of human brain metastasis-initiating cells.
Singh M; Venugopal C; Tokar T; Brown KR; McFarlane N; Bakhshinyan D; Vijayakumar T; Manoranjan B; Mahendram S; Vora P; Qazi M; Dhillon M; Tong A; Durrer K; Murty N; Hallet R; Hassell JA; Kaplan DR; Cutz JC; Jurisica I; Moffat J; Singh SK
Acta Neuropathol; 2017 Dec; 134(6):923-940. PubMed ID: 28766011
[TBL] [Abstract][Full Text] [Related]
3. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
[TBL] [Abstract][Full Text] [Related]
4. STAT3 pathway regulates lung-derived brain metastasis initiating cell capacity through miR-21 activation.
Singh M; Garg N; Venugopal C; Hallett R; Tokar T; McFarlane N; Mahendram S; Bakhshinyan D; Manoranjan B; Vora P; Qazi M; Arpin CC; Page B; Haftchenary S; Rosa DA; Lai PS; Gómez-Biagi RF; Ali AM; Lewis A; Geletu M; Murty NK; Hassell JA; Jurisica I; Gunning PT; Singh SK
Oncotarget; 2015 Sep; 6(29):27461-77. PubMed ID: 26314961
[TBL] [Abstract][Full Text] [Related]
5. An HLA-G/SPAG9/STAT3 axis promotes brain metastases.
Bassey-Archibong BI; Rajendra Chokshi C; Aghaei N; Kieliszek AM; Tatari N; McKenna D; Singh M; Kalpana Subapanditha M; Parmar A; Mobilio D; Savage N; Lam F; Tokar T; Provias J; Lu Y; Chafe SC; Swanton C; Hynds RE; Venugopal C; Singh SK
Proc Natl Acad Sci U S A; 2023 Feb; 120(8):e2205247120. PubMed ID: 36780531
[TBL] [Abstract][Full Text] [Related]
6. Pericytes in the Premetastatic Niche.
Paiva AE; Lousado L; Guerra DAP; Azevedo PO; Sena IFG; Andreotti JP; Santos GSP; Gonçalves R; Mintz A; Birbrair A
Cancer Res; 2018 Jun; 78(11):2779-2786. PubMed ID: 29789421
[TBL] [Abstract][Full Text] [Related]
7. AKR1B10 (Aldo-keto reductase family 1 B10) promotes brain metastasis of lung cancer cells in a multi-organ microfluidic chip model.
Liu W; Song J; Du X; Zhou Y; Li Y; Li R; Lyu L; He Y; Hao J; Ben J; Wang W; Shi H; Wang Q
Acta Biomater; 2019 Jun; 91():195-208. PubMed ID: 31034948
[TBL] [Abstract][Full Text] [Related]
8. Cochinchina momordica seed suppresses proliferation and metastasis in human lung cancer cells by regulating multiple molecular targets.
Shen Y; Meng L; Sun H; Zhu Y; Liu H
Am J Chin Med; 2015; 43(1):149-66. PubMed ID: 25649746
[TBL] [Abstract][Full Text] [Related]
9. Molecular Pathways Mediating Metastases to the Brain via Epithelial-to-Mesenchymal Transition: Genes, Proteins, and Functional Analysis.
Jeevan DS; Cooper JB; Braun A; Murali R; Jhanwar-Uniyal M
Anticancer Res; 2016 Feb; 36(2):523-32. PubMed ID: 26851006
[TBL] [Abstract][Full Text] [Related]
10. Predicting the sites of metastases from lung cancer using molecular biologic markers.
D'Amico TA; Aloia TA; Moore MB; Conlon DH; Herndon JE; Kinch MS; Harpole DH
Ann Thorac Surg; 2001 Oct; 72(4):1144-8. PubMed ID: 11603427
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic inhibition of MAP kinase interacting kinase blocks eukaryotic initiation factor 4E phosphorylation and suppresses outgrowth of experimental lung metastases.
Konicek BW; Stephens JR; McNulty AM; Robichaud N; Peery RB; Dumstorf CA; Dowless MS; Iversen PW; Parsons S; Ellis KE; McCann DJ; Pelletier J; Furic L; Yingling JM; Stancato LF; Sonenberg N; Graff JR
Cancer Res; 2011 Mar; 71(5):1849-57. PubMed ID: 21233335
[TBL] [Abstract][Full Text] [Related]
12. Impact of epidermal growth factor receptor mutations on intracranial treatment response and survival after brain metastases in lung adenocarcinoma patients.
Hsiao SH; Lin HC; Chou YT; Lin SE; Kuo CC; Yu MC; Chung CL
Lung Cancer; 2013 Sep; 81(3):455-461. PubMed ID: 23871711
[TBL] [Abstract][Full Text] [Related]
13. Expression profiling of angiogenesis-related genes in brain metastases of lung cancer and melanoma.
Ilhan-Mutlu A; Siehs C; Berghoff AS; Ricken G; Widhalm G; Wagner L; Preusser M
Tumour Biol; 2016 Jan; 37(1):1173-82. PubMed ID: 26277786
[TBL] [Abstract][Full Text] [Related]
14. Drug exposure in a metastatic human lung adenocarcinoma cell line gives rise to cells with differing adhesion, proliferation, and gene expression: Implications for cancer chemotherapy.
Li H; He J; Zhong N; Hoffman RM
Mol Med Rep; 2015 Sep; 12(3):3236-3242. PubMed ID: 26004767
[TBL] [Abstract][Full Text] [Related]
15. Targeting IL13Ralpha2 activates STAT6-TP63 pathway to suppress breast cancer lung metastasis.
Papageorgis P; Ozturk S; Lambert AW; Neophytou CM; Tzatsos A; Wong CK; Thiagalingam S; Constantinou AI
Breast Cancer Res; 2015 Jul; 17(1):98. PubMed ID: 26208975
[TBL] [Abstract][Full Text] [Related]
16. Unlocking molecular mechanisms and identifying druggable targets in matched-paired brain metastasis of breast and lung cancers.
Najjary S; de Koning W; Kros JM; Mustafa DAM
Front Immunol; 2023; 14():1305644. PubMed ID: 38149244
[TBL] [Abstract][Full Text] [Related]
17. AZD3759, a BBB-penetrating EGFR inhibitor for the treatment of EGFR mutant NSCLC with CNS metastases.
Yang Z; Guo Q; Wang Y; Chen K; Zhang L; Cheng Z; Xu Y; Yin X; Bai Y; Rabbie S; Kim DW; Ahn MJ; Yang JC; Zhang X
Sci Transl Med; 2016 Dec; 8(368):368ra172. PubMed ID: 27928026
[TBL] [Abstract][Full Text] [Related]
18. Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinoma.
Shih DJH; Nayyar N; Bihun I; Dagogo-Jack I; Gill CM; Aquilanti E; Bertalan M; Kaplan A; D'Andrea MR; Chukwueke U; Ippen FM; Alvarez-Breckenridge C; Camarda ND; Lastrapes M; McCabe D; Kuter B; Kaufman B; Strickland MR; Martinez-Gutierrez JC; Nagabhushan D; De Sauvage M; White MD; Castro BA; Hoang K; Kaneb A; Batchelor ED; Paek SH; Park SH; Martinez-Lage M; Berghoff AS; Merrill P; Gerstner ER; Batchelor TT; Frosch MP; Frazier RP; Borger DR; Iafrate AJ; Johnson BE; Santagata S; Preusser M; Cahill DP; Carter SL; Brastianos PK
Nat Genet; 2020 Apr; 52(4):371-377. PubMed ID: 32203465
[TBL] [Abstract][Full Text] [Related]
19. miR-448 is a novel prognostic factor of lung squamous cell carcinoma and regulates cells growth and metastasis by targeting DCLK1.
Shan C; Fei F; Li F; Zhuang B; Zheng Y; Wan Y; Chen J
Biomed Pharmacother; 2017 May; 89():1227-1234. PubMed ID: 28320089
[TBL] [Abstract][Full Text] [Related]
20. EGFR and KRAS Mutations Predict the Incidence and Outcome of Brain Metastases in Non-Small Cell Lung Cancer.
Tomasini P; Serdjebi C; Khobta N; Metellus P; Ouafik L; Nanni I; Greillier L; Loundou A; Fina F; Mascaux C; Barlesi F
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
